Solid Biosciences Inc (SLDB.OQ)
16 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-RA Capital Management Reports A 7.9 Pct Stake In Solid Biosciences
- BRIEF-Perceptive Advisors Reports 11.5 Pct Stake In Solid Biosciences As Of Jan 30
- BRIEF-BCLS SB Investco LP Reports 5.8 Pct Stake In Solid Biosciences As Of Jan 25
- BRIEF-Solid Biosciences Announces Pricing Of Initial Public Offering
- BRIEF-Solid Biosciences Says Now Sees IPO Of 7 Mln Shares Of Common Stock Priced Between $18-$19/Shr - SEC Filing